389 related articles for article (PubMed ID: 23002446)
21. Serotype IV Streptococcus agalactiae ST-452 has arisen from large genomic recombination events between CC23 and the hypervirulent CC17 lineages.
Campisi E; Rinaudo CD; Donati C; Barucco M; Torricelli G; Edwards MS; Baker CJ; Margarit I; Rosini R
Sci Rep; 2016 Jul; 6():29799. PubMed ID: 27411639
[TBL] [Abstract][Full Text] [Related]
22. Conjugate vaccines against group B Streptococcus types IV and VII.
Paoletti LC; Kasper DL
J Infect Dis; 2002 Jul; 186(1):123-6. PubMed ID: 12089673
[TBL] [Abstract][Full Text] [Related]
23. Invasive group B streptococcal infections in adults, France (2007-2010).
Tazi A; Morand PC; Réglier-Poupet H; Dmytruk N; Billoët A; Antona D; Trieu-Cuot P; Poyart C
Clin Microbiol Infect; 2011 Oct; 17(10):1587-9. PubMed ID: 21883671
[TBL] [Abstract][Full Text] [Related]
24. Fisher scientific award lecture - the capsular polysaccharides of Group B Streptococcus and Streptococcus suis differently modulate bacterial interactions with dendritic cells.
Segura M
Can J Microbiol; 2012 Mar; 58(3):249-60. PubMed ID: 22356626
[TBL] [Abstract][Full Text] [Related]
25. Multilocus sequence typing of Swedish invasive group B streptococcus isolates indicates a neonatally associated genetic lineage and capsule switching.
Luan SL; Granlund M; Sellin M; Lagergård T; Spratt BG; Norgren M
J Clin Microbiol; 2005 Aug; 43(8):3727-33. PubMed ID: 16081902
[TBL] [Abstract][Full Text] [Related]
26. Antibodies to capsular polysaccharides of group B Streptococcus in pregnant Canadian women: relationship to colonization status and infection in the neonate.
Davies HD; Adair C; McGeer A; Ma D; Robertson S; Mucenski M; Kowalsky L; Tyrell G; Baker CJ
J Infect Dis; 2001 Aug; 184(3):285-91. PubMed ID: 11443553
[TBL] [Abstract][Full Text] [Related]
27. Use of a serotype-specific DNA microarray for identification of group B Streptococcus (Streptococcus agalactiae).
Wen L; Wang Q; Li Y; Kong F; Gilbert GL; Cao B; Wang L; Feng L
J Clin Microbiol; 2006 Apr; 44(4):1447-52. PubMed ID: 16597875
[TBL] [Abstract][Full Text] [Related]
28. Synthesis and preclinical evaluation of glycoconjugate vaccines against group B Streptococcus types VI and VIII.
Paoletti LC; Pinel J; Johnson KD; Reinap B; Ross RA; Kasper DL
J Infect Dis; 1999 Sep; 180(3):892-5. PubMed ID: 10438388
[TBL] [Abstract][Full Text] [Related]
29. A practical method for subtyping of Streptococcus agalactiae serotype III, of human origin, using rolling circle amplification.
Tong Z; Kong F; Wang B; Zeng X; Gilbert GL
J Microbiol Methods; 2007 Jul; 70(1):39-44. PubMed ID: 17467090
[TBL] [Abstract][Full Text] [Related]
30. Genomic insights into the diversity, virulence, and antimicrobial resistance of group B
Alzayer M; Alkhulaifi MM; Alyami A; Aldosary M; Alageel A; Garaween G; Shibl A; Al-Hamad AM; Doumith M
Front Cell Infect Microbiol; 2024; 14():1377993. PubMed ID: 38711928
[TBL] [Abstract][Full Text] [Related]
31. Outbreak of late-onset group B Streptococcus in a neonatal intensive care unit.
MacFarquhar JK; Jones TF; Woron AM; Kainer MA; Whitney CG; Beall B; Schrag SJ; Schaffner W
Am J Infect Control; 2010 May; 38(4):283-8. PubMed ID: 20022407
[TBL] [Abstract][Full Text] [Related]
32. Safety and immunogenicity of a bivalent group B streptococcal conjugate vaccine for serotypes II and III.
Baker CJ; Rench MA; Fernandez M; Paoletti LC; Kasper DL; Edwards MS
J Infect Dis; 2003 Jul; 188(1):66-73. PubMed ID: 12825173
[TBL] [Abstract][Full Text] [Related]
33. Genetic differences between invasive and noninvasive neonatal group B streptococcal isolates.
Fluegge K; Wons J; Spellerberg B; Swoboda S; Siedler A; Hufnagel M; Berner R
Pediatr Infect Dis J; 2011 Dec; 30(12):1027-31. PubMed ID: 21775921
[TBL] [Abstract][Full Text] [Related]
34. Evidence for rare capsular switching in Streptococcus agalactiae.
Martins ER; Melo-Cristino J; Ramirez M
J Bacteriol; 2010 Mar; 192(5):1361-9. PubMed ID: 20023016
[TBL] [Abstract][Full Text] [Related]
35. Molecular characteristics of group B Streptococcus isolates from infants in southern mainland China.
Li J; Ji W; Gao K; Zhou H; Zhang L; Mu X; Yuan C; Guan X; Deng Q; Zhang L; Zhong H; Gao X; Gao F; Long Y; Chang CY; McIver DJ; Liu H
BMC Infect Dis; 2019 Sep; 19(1):812. PubMed ID: 31533652
[TBL] [Abstract][Full Text] [Related]
36. Recombinant group B streptococcus Beta C protein and a variant with the deletion of its immunoglobulin A-binding site are protective mouse maternal vaccines and effective carriers in conjugate vaccines.
Yang HH; Madoff LC; Guttormsen HK; Liu YD; Paoletti LC
Infect Immun; 2007 Jul; 75(7):3455-61. PubMed ID: 17470542
[TBL] [Abstract][Full Text] [Related]
37. Capsular polysaccharide of Streptococcus agalactiae is an essential virulence factor for infection in Nile tilapia (Oreochromis niloticus Linn.).
Zhang D; Ke X; Liu Z; Cao J; Su Y; Lu M; Gao F; Wang M; Yi M; Qin F
J Fish Dis; 2019 Feb; 42(2):293-302. PubMed ID: 30549284
[TBL] [Abstract][Full Text] [Related]
38. Use of type V group B streptococcal conjugate vaccine in adults 65-85 years old.
Palazzi DL; Rench MA; Edwards MS; Baker CJ
J Infect Dis; 2004 Aug; 190(3):558-64. PubMed ID: 15243932
[TBL] [Abstract][Full Text] [Related]
39. Invasive group B streptococcal infections in infants, France.
Poyart C; Réglier-Poupet H; Tazi A; Billoët A; Dmytruk N; Bidet P; Bingen E; Raymond J; Trieu-Cuot P
Emerg Infect Dis; 2008 Oct; 14(10):1647-9. PubMed ID: 18826837
[TBL] [Abstract][Full Text] [Related]
40. Surface Structures of Group B
Paoletti LC; Kasper DL
Microbiol Spectr; 2019 Mar; 7(2):. PubMed ID: 30873933
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
